AI IntelligenceJun 19, 2026Secondary Market
Article
RXRX
Recursion Pharmaceuticals filed an 8-K regarding the submission of matters to a vote of security holders. This is a routine disclosure following the annual meeting.
Data Cube AI EditorialSource: SEC EDGAR
01
Source Brief
Recursion Pharmaceuticals filed an 8-K regarding the submission of matters to a vote of security holders. This is a routine disclosure following the annual meeting.
02